Back to School: How biopharma can reboot drug development. Access exclusive analysis here

SMART 1D10 Antibody: Phase I

Preliminary results from 10 evaluable patients in a U.S.

Read the full 93 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE